Abstract
Neuro-oncological and neurodegenerative disorders, represented paradigmatically by glioblastoma and Alzheimer's disease, respectively, persist as formidable challenges in the biomedical realm. The interconnected molecular underpinnings of these conditions necessitate rigorous and novel therapeutic examinations. This comprehensive research was anchored on the premise of unveiling the therapeutic potential and specificity of Lupenone, a potent phytoconstituent, in targeting the molecular pathways underpinning both glioblastoma and Alzheimer's amyloid beta pathology. This was gauged through its interactions with key protein structures, 5H08 and 2ZHV. An integrative approach was adopted, marrying advanced proteomics and modern computer-aided drug design techniques. Molecular docking of Lupenone with 5H08 and 2ZHV was meticulously executed, with subsequent molecular dynamics simulations providing insights into the stability, viability, and intricacies of these interactions. Lupenone demonstrated profound binding affinities, evidenced by robust docking scores of -9.54 kcal/mol for 5H08 and -10.59 kcal/mol for 2ZHV. These interactions underscored Lupenone's eminent therapeutic potential in mitigating glioblastoma and modulating the amyloid beta pathology inherent to Alzheimer's. The introduction of Proteolysis Targeting Chimeras (PROTACs) further magnified the therapeutic prospects, accentuating Lupenone's efficacy. The findings of this study not only underscore the therapeutic acumen of Lupenone in addressing the challenges posed by glioblastoma and Alzheimer's but also lay a strong foundation for its consideration as a leading candidate in future neuro-oncological and neurodegenerative research endeavors. Given the compelling in-silico data, a clarion call is made for its empirical validation in holistic in-vivo settings, potentially pioneering a new therapeutic epoch in both glioblastoma and Alzheimer's interventions.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data availability
The data used or analyzed during this study are available on reasonable request from the corresponding author.
References
Atkinson GP, Nozell SE, Benveniste ETN (2010) NF-κB and STAT3 signaling in glioma: targets for future therapies. Expert Rev Neurother 10(4):575–586
Atiq A, Parhar I (2020) Anti-neoplastic potential of flavonoids and polysaccharide phytochemicals in glioblastoma. Molecules 25(21):4895
Békés M, Langley DR, Crews CM (2022) PROTAC targeted protein degraders: the past is prologue. Nat Rev Drug Discov 21(3):181–200
Bowers KJ, Chow E, Xu H, Dror RO, Eastwood MP, Gregersen BA, Klepeis JL, Kolossvary I, Moraes MA, Sacerdoti FD, Salmon JK (2006) Scalable algorithms for molecular dynamics simulations on commodity clusters. In: Proceedings of the 2006 ACM/IEEE Conference on Supercomputing 2006 Nov 11 (pp 84-es)
Chen PY, Tuckerman ME (2018) Molecular dynamics based enhanced sampling of collective variables with very large time steps. J Chem Phys 148(2):024106
Chow E, Rendleman CA, Bowers KJ, Dror RO, Hughes DH, Gullingsrud J, Sacerdoti FD, Shaw DE (2008) Desmond performance on a cluster of multicore processors. DE Shaw Research Technical Report DESRES/TR--2008-01
Desai V, Bhushan A (2017) Natural bioactive compounds: Alternative approach to the treatment of glioblastoma multiforme. BioMed research international. https://doi.org/10.1155/2017/9363040
Din NU, Ishtiaq H, Rahim S, Abdul-Ghafar J, Ahmad Z (2021) Gliosarcoma in patients under 20 years of age. A clinicopathologic study of 11 cases and detailed review of the literature. BMC Pediatr 21(1):1–10
Eberlin LS, Norton I, Dill AL, Golby AJ, Ligon KL, Santagata S, ... Agar NY (2012) Classifying human brain tumors by lipid imaging with mass spectrometryhuman gliomas are classified by subtype, grade, and cell concentration. Cancer Res 72(3):645–654
Ferreira LG, Dos Santos RN, Oliva G, Andricopulo AD (2015) Molecular docking and structure-based drug design strategies. Molecules 20(7):13384–13421
Ghosh A, Chakraborty D, Mukerjee N, Baishya D, Chigurupati S, Felemban SG, Almahmoud SA, Almikhlafi MA, Sehgal A, Singh S, Sharma N (2023) Target-based virtual screening and molecular interaction studies for lead identification of natural olive compounds against glioblastoma multiforme. Environ Sci Pollut Res 30(3):6170–6191. https://doi.org/10.1007/s11356-022-22401-5
Jawarkar RD, Sharma P, Jain N, Gandhi A, Mukerjee N, Al-Mutairi AA, ... Bakal RL (2022) QSAR, Molecular Docking, MD Simulation and MMGBSA calculations approaches to recognize concealed pharmacophoric features requisite for the optimization of ALK tyrosine kinase inhibitors as anticancer leads. Molecules 27(15):4951
Jorgensen WL, Maxwell DS, Tirado-Rives J (1996) Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids. J Am Chem Soc 118(45):11225–11236
Martins M, Mesquita LMDS, Vaz BM, Dias AC, Torres-Acosta MA, Quéguineur B, ... Ventura SP (2021) Extraction and fractionation of pigments from Saccharina latissima (Linnaeus, 2006) using an ionic liquid+ oil+ water System. ACS Sustain Chem Eng 9(19):6599–6612
Martyna GJ, Tobias DJ, Klein ML (1994) Constant pressure molecular dynamics algorithms. J Chem Phys 101(5):4177–4189
Mitsis D, Francescutti V, Skitzki J (2016) Current immunotherapies for sarcoma: clinical trials and rationale. Sarcoma 2016. https://doi.org/10.1155/2016/9757219
Morris GM, Goodsell DS, Huey R, Olson AJ (1996) Distributed automated docking of flexible ligands to proteins: parallel applications of AutoDock 2.4. J Comput-Aided Mol Des 10(4):293–304
Mukerjee N, Das A, Jawarkar RD, Maitra S, Das P, Castrosanto MA, Paul S, Samad A, Zaki ME, Al-Hussain SA, Masand VH (2022a) Repurposing food molecules as a potential BACE1 inhibitor for Alzheimer’s disease. Front Aging Neurosci 14:878276. https://doi.org/10.3389/fnagi.2022.878276
Mukerjee N, Maitra S, Roy S, Modak S, Hasan MM, Chakraborty B, Ghosh A, Ghosh A, Kamal MA, Dey A, Ashraf GM (2022b) Treatments against Polymorphosal discrepancies in Glioblastoma Multiforme. Metab Brain Dis 38(1):61–68. https://doi.org/10.1007/s11011-022-01082-6
Mukerjee N, Ghosh A (2023) Revolutionizing viral disease treatment: PROTACs therapy could be the ultimate weapon of the future. J Med Virol 95(8):e28981. https://doi.org/10.1002/jmv.28981
Mukerjee N, Maitra S, Ghosh A, Subramaniyan V, Sharma R (2023) Exosome‐mediated PROTACs delivery to target viral infections. Drug Dev Res 84(6):1031–1036. https://doi.org/10.1002/ddr.22091
Sakai S, Kawamata H, Kogure T, Mantani N, Terasawa K, Umatake M, Ochiai H (1999) Inhibitory effect of ferulic acid and isoferulic acid on the production of macrophage inflammatory protein-2 in response to respiratory syncytial virus infection in RAW264. 7 cells. Mediat Inflamm 8(3):173–175
Seth S, Debnath S, Chakraborty NR (2020) In silico analysis of functional linkage among arsenic induced MATE genes in rice. Biotechnol Rep 26:e00390
Shivakumar D, Williams J, Wu Y, Damm W, Shelley J, Sherman W (2010) Prediction of absolute solvation free energies using molecular dynamics free energy perturbation and the OPLS force field. J Chem Theory Comput 6(5):1509–1519
Singh AK, Khan IR, Khan S, Pant K, Debnath S, Miah S (2022) Multichannel CNN model for biomedical entity reorganization. BioMed Research International 2022. https://doi.org/10.1155/2022/5765629
Sloot S, Chen YA, Zhao X, Weber JL, Benedict JJ, Mulé JJ, ... Gibney GT (2018) Improved survival of patients with melanoma brain metastases in the era of targeted BRAF and immune checkpoint therapies. Cancer 124(2):297–305
Suk K (2012) Proteomic analysis of glioma chemoresistance. Curr Neuropharmacol 10(1):72–79
Toukmaji AY, Board JA Jr (1996) Ewald summation techniques in perspective: a survey. Comput Phys Commun 95(2–3):73–92
Valentová K, Šeršeň F, Ulrichová J (2005) Radical scavenging and anti-lipoperoxidative activities of Smallanthus sonchifolius leaf extracts. J Agric Food Chem 53(14):5577–5582
Wang Y, Jiang T (2013) Understanding high grade glioma: molecular mechanism, therapy and comprehensive management. Cancer Lett 331(2):139–146
Wesseling P, Kros JM, Jeuken JW (2011) The pathological diagnosis of diffuse gliomas: towards a smart synthesis of microscopic and molecular information in a multidisciplinary context. Diagn Histopathol 17(11):486–494
Yao Y, Zhou Y, Liu L, Xu Y, Chen Q, Wang Y, ... Shao A (2020) Nanoparticle-based drug delivery in cancer therapy and its role in overcoming drug resistance. Front Mol Biosci 7:193
Acknowledgements
Princess Nourah bint Abdulrahman University Researchers Supporting Project Number (PNURSP2023R213), Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
Funding
Princess Nourah bint Abdulrahman University Researchers Supporting Project Number (PNURSP2023R213), Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
Author information
Authors and Affiliations
Contributions
Conceptualization: HMA, AII & FAB. Methodology: WAA, RSA & MHS. Software and Visualization: WAA, RSA, YMA & HMA. Formal analysis: ASMA, FAB, BSMA & HMA. Investigation: MHS, BSMA & HMA. Writing original draft preparation: HMA, AII & FAB & WAA. Editing: MHS, AII & FAB, WAA & HMA. Supervision: ASMA, FAB, BSMA. Project administration: HMA & WAA. Funding acquisition, Hailah M. Almohaimeed. Submission, MHS. All authors have read and agreed to the published version of the manuscript.
Corresponding author
Ethics declarations
Ethics approval
The study was conducted according to the guidelines of the Declaration and approved by the Committee of Princess Nourah bint Abdulrahman, University.
Consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare no competing interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Almohaimeed, H.M., Almars, A.I., Al Abdulmonem, W. et al. Molecular dynamics exploration of Lupenone: therapeutic implications for glioblastoma multiforme and alzheimer's amyloid beta pathogenesis. Metab Brain Dis 39, 77–88 (2024). https://doi.org/10.1007/s11011-023-01319-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-023-01319-y